pharma: At the right time, money can be made in pharma; hold on to HDFC Bank: Mayuresh Joshi
"NIM contraction might be very marginal in HDFC Bank. Advances growth should be extremely strong. Again, purely in terms of their advances and deposit growth, the numbers are pretty humongous . All the tech issues are largely behind them. Even if valuations are at a premium, which it has always commanded, the second half numbers should be relatively better."
Source: indiatimes.com